However, recent study showed an increased plasma LCAT activity on average 12% higher in subjects with a fatty liver index (FLI) ≥ 60 as well as in insulin-resistant conditions, like obesity, T2DM, and MetS (Kaya et al., 2013). The gene discussed is LCAT; the disease is type 2 diabetes mellitus.